Li Zhao
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Retinal Development and Disorders 10
- RNA modifications and cancer 10
- RNA Research and Splicing 9
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 9
- Co-authors
- Zhang Zhang (10 shared papers)Lina Ma (8 shared papers)Lin Liu (6 shared papers)Rui Chen (12 shared papers)Dong Zou (5 shared papers)Yumei Li (9 shared papers)Qiang Du (2 shared papers)Feng Wang (7 shared papers)
- Journals
- Nucleic Acids Research (8 papers)Investigative Ophthalmology & Visual Science (4 papers)China CDC Weekly (3 papers)Nature Communications (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Li Zhao
220 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 181
- Cancer Research 578
- Infectious Diseases 456
- Hematology 256
- Molecular Biology 1.4k
- Parasitology 128
Countries citing papers authored by Li Zhao
This map shows the geographic impact of Li Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhao more than expected).
Fields of papers citing papers by Li Zhao
This network shows the impact of papers produced by Li Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhao. The network helps show where Li Zhao may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 238 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 259 | |
| 2 | 2020 | 232 | |
| 3 | 2020 | 230 | |
| 4 | 2018 | 165 | |
| 5 | 2019 | 91 | |
| 6 | 2020 | 89 | |
| 7 | 2014 | 74 | |
| 8 | 2013 | 72 | |
| 9 | 2016 | 67 | |
| 10 | 2020 | 66 | |
| 11 | 2015 | 64 | |
| 12 | 2016 | 64 | |
| 13 | 2018 | 62 | |
| 14 | 2022 | 60 | |
| 15 | 2017 | 55 | |
| 16 | 2015 | 55 | |
| 17 | The lncRNA-HOXA-AS2/EZH2/LSD1 oncogene complex promotes cell proliferation in pancreatic cancer. | 2017 | 55 |
| 18 | 2010 | 53 | |
| 19 | 2019 | 52 | |
| 20 | 2021 | 49 |
About Li Zhao
Li Zhao is a scholar working on Molecular Biology, Cancer Research, Plant Science, Infectious Diseases and Mechanics of Materials, having authored 238 papers that have together received 4.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (13 papers), Cancer-related molecular mechanisms research (11 papers), Retinal Development and Disorders (10 papers), RNA modifications and cancer (10 papers), Mechanical Behavior of Composites (10 papers), RNA Research and Splicing (9 papers), MicroRNA in disease regulation (9 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Cancer Research (578 citations), Infectious Diseases (456 citations), Hematology (256 citations), Molecular Biology (1.4k citations) and Parasitology (128 citations). Li Zhao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhang Zhang, Lina Ma, Lin Liu, Rui Chen, Dong Zou, Yumei Li, Qiang Du, Feng Wang, P. Andrew Futreal and Vladimir B. Bajić. Their work appears in journals such as Nucleic Acids Research, Investigative Ophthalmology & Visual Science, China CDC Weekly, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.